Author: Kanwarpal S. Bakshi, MD – Children’s Hospital Los Angeles
A 6-month-old infant undergoes tetralogy of Fallot repair and separates uneventfully from cardiopulmonary bypass. After administration of protamine sulfate, the mean arterial pressure (MAP) rapidly decreases from 55 to 35 mmHg. Transesopageal echocardiography (TEE) demonstrates acute RV dilation with severe RV dysfunction, an estimated right ventricular systolic pressure (RVSP) of 64 mmHg, and a small, underfilled LV. The ventilator shows normal peak pressures with diminishing end-tidal CO2. Which of the following BEST explains the pathophysiology of this protamine reaction?
EXPLANATION
Protamine is a highly basic, positively charged polypeptide used to neutralize the anticoagulant effects of unfractionated heparin following cardiopulmonary bypass. Through electrostatic interactions, protamine binds negatively charged heparin to form a stable complex with minimal anticoagulant activity. Although protamine is routinely administered during cardiac surgery, adverse reactions may occur ranging from transient hypotension to severe cardiovascular and pulmonary compromise.1-4
Acute adverse reactions to protamine are traditionally classified into three clinical types.1 Type I reactions are primarily related to the rate of protamine administration. Rapid intravenous administration (answer choice A) can produce systemic hypotension, in part through histamine-mediated vasodilation and a reduction in systemic vascular resistance.1-4 Therefore, protamine should be administered over several minutes rather than as a rapid bolus. Generally, a test dose can mitigate such reactions, but does not preclude them from occuring.
Type II reactions represent anaphylactic or anaphylactoid responses. Patients with preexisting anti-protamine IgE (answer choice B) IgG antibodies may experience mast cell and basophil activation. This activation results in the release of multiple vasoactive mediators and subsequent systemic vasodilation, hypotension, bronchospasm, and other manifestations of hypersensitivity.2 Prior exposure to protamine-containing insulin preparations, particularly NPH insulin, has been associated with anti-protamine antibodies and increased risk of severe reactions.2-4 Of note, fish allergy should not be equated with protamine allergy. Although commercial protamine has historically been derived from salmon sperm, available evidence does not establish clinically important cross-reactivity between fish-specific IgE and protamine. 3,4
The physiology in this case is most consistent with a type III protamine reaction, characterized by catastrophic pulmonary vasoconstriction. Protamine-heparin complexes can activate the complement cascade, generating anaphylatoxins including C3a and C5a. These inflammatory pathways can promote the generation of thromboxane A₂ (answer choice C), producing profound pulmonary vasoconstriction.2-4 The resulting increase in pulmonary vascular resistance causes an abrupt increase in RV afterload. The RV acutely dilates and develops systolic dysfunction, while pulmonary blood flow falls. Consequently, pulmonary venous return and LV preload decrease, producing the scenario seen in this patient.
Management of a suspected severe protamine reaction should begin with immediate discontinuation of protamine and prompt assessment of the underlying hemodynamic disturbance. In type I reactions, supportive measures including appropriate volume resuscitation and vasoactive support should be undertaken, in addition to slowing the rate of protamine administration. Type II reactions require treatment similar to other severe hypersensitivity reactions, including epinephrine for significant cardiovascular or respiratory compromise. In type III reactions, management is directed toward reducing pulmonary vascular resistance and supporting the failing right ventricle. This includes optimization of oxygenation and ventilation, avoidance of hypoxemia, hypercarbia, and acidosis, consideration of inhaled pulmonary vasodilators, and institution of appropriate vasoactive and inotropic support. In severe, refractory cases, reinstitution of cardiopulmonary bypass or extracorporeal mechanical support may be required.
REFERENCES
1. Horrow JC. Protamine: a review of its toxicity. Anesth Analg . 1985;64(3):348-361. doi:10.1213/00000539-198503000-00008.
2. Levy JH, Ghadimi K, Kizhakkedathu JN, Iba T. What's fishy about protamine? Clinical use, adverse reactions, and potential alternatives. J Thromb Haemost. 2023;21(7):1714-1723. doi:10.1016/j.jtha.2023.04.005.
3. Park KW. Protamine and protamine reactions. Int Anesthesiol Clin. 2004;42(3):135-145. doi:10.1097/00004311-200404230-00011
4. Protamine (rc207). Thermo Fisher Scientific Allergen Encyclopedia. Thermo Fisher Scientific. Accessed September 25, 2026. thermofisher.com